Search
Search
Invitrogen
{{$productOrderCtrl.translations['antibody.pdp.commerceCard.promotion.promotions']}}
{{$productOrderCtrl.translations['antibody.pdp.commerceCard.promotion.viewpromo']}}
{{$productOrderCtrl.translations['antibody.pdp.commerceCard.promotion.promocode']}}: {{promo.promoCode}} {{promo.promoTitle}} {{promo.promoDescription}}. {{$productOrderCtrl.translations['antibody.pdp.commerceCard.promotion.learnmore']}}
图: 1 / 7
KIR2DL2 and KIR2DL3 are genes belonging to the killer cell immunoglobulin-like receptor (KIR) family, located on chromosome 19q13.4. They encode inhibitory receptors expressed primarily on natural killer (NK) cells and a subset of T cells. The proteins produced by these genes play a key role in regulating the immune response through their interaction with human leukocyte antigen (HLA) class I molecules, specifically HLA-C alleles. KIR2DL2 recognizes a broad range of HLA-C alleles with a lysine at position 80 (C1 group), while KIR2DL3 has a higher affinity for the HLA-C1 group. Structurally, these receptors consist of two extracellular immunoglobulin-like domains, a transmembrane region, and a long cytoplasmic tail that contains immunoreceptor tyrosine-based inhibitory motifs (ITIMs). Upon ligand binding, these receptors transmit inhibitory signals to prevent NK cell activation, thereby protecting healthy cells from immune destruction.
仅用于科研。不用于诊断过程。未经明确授权不得转售。